Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

The modulation of phosphatase expression impacts the proliferation efficiency of HSV-1 in infected astrocytes.

Yue L, Guo S, Zhang Y, Liu L, Wang Q, Wang X, Shen D, Wang L, Sun L, Wang J, Liao Y, Li Q.

PLoS One. 2013 Nov 15;8(11):e79648. doi: 10.1371/journal.pone.0079648. eCollection 2013.

2.

PNKP knockdown by RNA interference inhibits herpes simplex virus-1 replication in astrocytes.

Yue L, Guo S, Cao X, Zhang Y, Sun L, Liu L, Yan M, Li Q.

Virol Sin. 2013 Dec;28(6):345-51. doi: 10.1007/s12250-013-3350-5. Epub 2013 Nov 6.

PMID:
24213989
3.

Herpes simplex virus type 1 induces simultaneous activation of Toll-like receptors 2 and 4 and expression of the endogenous ligand serum amyloid A in astrocytes.

Villalba M, Hott M, Martin C, Aguila B, Valdivia S, Quezada C, Zambrano A, Concha MI, Otth C.

Med Microbiol Immunol. 2012 Aug;201(3):371-9. doi: 10.1007/s00430-012-0247-0. Epub 2012 May 24.

PMID:
22622619
4.

Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1.

Lerchundi R, Neira R, Valdivia S, Vio K, Concha MI, Zambrano A, Otth C.

J Alzheimers Dis. 2011;23(3):513-20. doi: 10.3233/JAD-2010-101386.

PMID:
21098975
5.

A role for DNA-dependent activator of interferon regulatory factor in the recognition of herpes simplex virus type 1 by glial cells.

Furr SR, Chauhan VS, Moerdyk-Schauwecker MJ, Marriott I.

J Neuroinflammation. 2011 Aug 12;8:99. doi: 10.1186/1742-2094-8-99.

6.

Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells.

Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, Abhyankar A, Ying SW, Keros S, Goldstein PA, Mostoslavsky G, Ordovas-Montanes J, Jouanguy E, Plancoulaine S, Tu E, Elkabetz Y, Al-Muhsen S, Tardieu M, Schlaeger TM, Daley GQ, Abel L, Casanova JL, Studer L, Notarangelo LD.

Nature. 2012 Nov 29;491(7426):769-73. doi: 10.1038/nature11583. Epub 2012 Oct 28.

7.

Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons.

Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, Ho W.

Glia. 2011 Jan;59(1):58-67. doi: 10.1002/glia.21076. Epub 2010 Sep 27.

8.

Induction of interferon-γ contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes.

Li J, Ye L, Wang X, Hu S, Ho W.

J Neurosci Res. 2012 Feb;90(2):399-406. doi: 10.1002/jnr.22758. Epub 2011 Nov 4.

9.

The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling.

Cotter CR, Kim WK, Nguyen ML, Yount JS, López CB, Blaho JA, Moran TM.

J Virol. 2011 Dec;85(23):12662-72. doi: 10.1128/JVI.05557-11. Epub 2011 Sep 21.

10.

TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice.

Reinert LS, Harder L, Holm CK, Iversen MB, Horan KA, Dagnæs-Hansen F, Ulhøi BP, Holm TH, Mogensen TH, Owens T, Nyengaard JR, Thomsen AR, Paludan SR.

J Clin Invest. 2012 Apr;122(4):1368-76. doi: 10.1172/JCI60893. Epub 2012 Mar 19.

11.
12.

A proautophagic antiviral role for the cellular prion protein identified by infection with a herpes simplex virus 1 ICP34.5 mutant.

Korom M, Wylie KM, Wang H, Davis KL, Sangabathula MS, Delassus GS, Morrison LA.

J Virol. 2013 May;87(10):5882-94. doi: 10.1128/JVI.02559-12. Epub 2013 Mar 13.

13.

Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.

Caignard G, Leiva-Torres GA, Leney-Greene M, Charbonneau B, Dumaine A, Fodil-Cornu N, Pyzik M, Cingolani P, Schwartzentruber J, Dupaul-Chicoine J, Guo H, Saleh M, Veillette A, Lathrop M, Blanchette M, Majewski J, Pearson A, Vidal SM.

PLoS Pathog. 2013 Sep;9(9):e1003637. doi: 10.1371/journal.ppat.1003637. Epub 2013 Sep 12.

14.

Simian TRIM5alpha proteins reduce replication of herpes simplex virus.

Reszka N, Zhou C, Song B, Sodroski JG, Knipe DM.

Virology. 2010 Mar 15;398(2):243-50. doi: 10.1016/j.virol.2009.11.041. Epub 2010 Jan 12.

15.

Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.

Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ.

Antiviral Res. 2006 Dec;72(3):242-51. Epub 2006 Jul 14.

PMID:
16876885
16.

Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.

Broberg EK, Peltoniemi J, Nygårdas M, Vahlberg T, Röyttä M, Hukkanen V.

J Virol. 2004 Dec;78(23):13139-52.

17.

Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells.

Immergluck LC, Domowicz MS, Schwartz NB, Herold BC.

J Gen Virol. 1998 Mar;79 ( Pt 3):549-59.

PMID:
9519833
18.

Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication.

Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Fujii N.

Virology. 2005 Jul 20;338(1):173-81.

19.

A cellular response protein induced during HSV-1 infection inhibits viral replication by interacting with ATF5.

Wu L, Zhang X, Che Y, Zhang Y, Tang S, Liao Y, Na R, Xiong X, Liu L, Li Q.

Sci China Life Sci. 2013 Dec;56(12):1124-33. doi: 10.1007/s11427-013-4569-y. Epub 2013 Dec 5.

PMID:
24302293
20.

Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.

Pierce AT, DeSalvo J, Foster TP, Kosinski A, Weller SK, Halford WP.

J Gen Virol. 2005 Sep;86(Pt 9):2421-32.

Supplemental Content

Support Center